Drastic antitumor response following administration of afatinib immediately after atezolizumab in a patient with epidermal growth factor receptor tyrosine kinase inhibitor‐resistant lung cancer

Detalles Bibliográficos
Autores principales: Sumi, Toshiyuki, Nakata, Hisashi, Chiba, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Case Image
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258357/
https://www.ncbi.nlm.nih.gov/pubmed/34096184
http://dx.doi.org/10.1111/1759-7714.14047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258357/
https://www.ncbi.nlm.nih.gov/pubmed/34096184
http://dx.doi.org/10.1111/1759-7714.14047

Ejemplares similares